CA Patent

CA2412790A1 — Liposomal antineoplastic drugs and uses thereof

Assigned to Talon Therapeutics Inc · Expires 2002-01-10 · 24y expired

What this patent protects

This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an…

USPTO Abstract

This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.

Drugs covered by this patent

Patent Metadata

Patent number
CA2412790A1
Jurisdiction
CA
Classification
—
Expires
2002-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Talon Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.